Scientific Opinion on the substantiation of a health claim related to fermented milk containing Lactobacillus casei DN-114 001 plus yoghurt symbiosis (Actimel®), and reduction of Clostridium difficile toxins in the gut of patients receiving antibiotics and reduced risk of acute diarrhoea in patients receiving antibiotics pursuant to Article 14 of Regulation (EC) No 1924/2006: EFSA-Q-2009-00776

Inge Tetens

Scientific Opinion on the substantiation of a health claim related to fermented milk containing Lactobacillus casei DN-114 001 plus yoghurt symbiosis (Actimel®), and reduction of Clostridium difficile toxins in the gut of patients receiving antibiotics and reduced risk of acute diarrhoea in patients receiving antibiotics pursuant to Article 14 of Regulation (EC) No 1924/2006: EFSA-Q-2009-00776

Inge Tetens

National Food Institute

Research output: Book/Report › Report › Research › peer-review

Original language	English

Publisher	European Food Safety Authority
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Clostridium difficile toxin
risk reduction
Lactobacillus delbrueckii subsp. bulgaricus
Actimel®
yoghurt
microbiota, intestine
diarrhoea
Streptococcus thermophilus
Lactobacillus casei DN-114 001
elderly
fermented milk
antibiotic treatment

OpenUrl availability

Full text

Cite this

Tetens, I. (2010). Scientific Opinion on the substantiation of a health claim related to fermented milk containing Lactobacillus casei DN-114 001 plus yoghurt symbiosis (Actimel®), and reduction of Clostridium difficile toxins in the gut of patients receiving antibiotics and reduced risk of acute diarrhoea in patients receiving antibiotics pursuant to Article 14 of Regulation (EC) No 1924/2006: EFSA-Q-2009-00776. European Food Safety Authority.

Tetens, Inge. / Scientific Opinion on the substantiation of a health claim related to fermented milk containing Lactobacillus casei DN-114 001 plus yoghurt symbiosis (Actimel®), and reduction of Clostridium difficile toxins in the gut of patients receiving antibiotics and reduced risk of acute diarrhoea in patients receiving antibiotics pursuant to Article 14 of Regulation (EC) No 1924/2006 : EFSA-Q-2009-00776. European Food Safety Authority, 2010.

@book{1767cf4d9c0649f3b5871c69f0a7bcd6,

title = "Scientific Opinion on the substantiation of a health claim related to fermented milk containing Lactobacillus casei DN-114 001 plus yoghurt symbiosis (Actimel{\textregistered}), and reduction of Clostridium difficile toxins in the gut of patients receiving antibiotics and reduced risk of acute diarrhoea in patients receiving antibiotics pursuant to Article 14 of Regulation (EC) No 1924/2006: EFSA-Q-2009-00776",

keywords = "Clostridium difficile toxin, risk reduction, Lactobacillus delbrueckii subsp. bulgaricus, Actimel{\textregistered}, yoghurt, microbiota, intestine, diarrhoea, Streptococcus thermophilus, Lactobacillus casei DN-114 001, elderly, fermented milk, antibiotic treatment",

author = "Inge Tetens",

year = "2010",

language = "English",

publisher = "European Food Safety Authority",

}

Tetens, I 2010, Scientific Opinion on the substantiation of a health claim related to fermented milk containing Lactobacillus casei DN-114 001 plus yoghurt symbiosis (Actimel®), and reduction of Clostridium difficile toxins in the gut of patients receiving antibiotics and reduced risk of acute diarrhoea in patients receiving antibiotics pursuant to Article 14 of Regulation (EC) No 1924/2006: EFSA-Q-2009-00776. European Food Safety Authority.

Scientific Opinion on the substantiation of a health claim related to fermented milk containing Lactobacillus casei DN-114 001 plus yoghurt symbiosis (Actimel®), and reduction of Clostridium difficile toxins in the gut of patients receiving antibiotics and reduced risk of acute diarrhoea in patients receiving antibiotics pursuant to Article 14 of Regulation (EC) No 1924/2006: EFSA-Q-2009-00776. / Tetens, Inge.
European Food Safety Authority, 2010.

Research output: Book/Report › Report › Research › peer-review

TY - RPRT

T1 - Scientific Opinion on the substantiation of a health claim related to fermented milk containing Lactobacillus casei DN-114 001 plus yoghurt symbiosis (Actimel®), and reduction of Clostridium difficile toxins in the gut of patients receiving antibiotics and reduced risk of acute diarrhoea in patients receiving antibiotics pursuant to Article 14 of Regulation (EC) No 1924/2006

T2 - EFSA-Q-2009-00776

AU - Tetens, Inge

PY - 2010

Y1 - 2010

KW - Clostridium difficile toxin

KW - risk reduction

KW - Lactobacillus delbrueckii subsp. bulgaricus

KW - Actimel®

KW - yoghurt

KW - microbiota, intestine

KW - diarrhoea

KW - Streptococcus thermophilus

KW - Lactobacillus casei DN-114 001

KW - elderly

KW - fermented milk

KW - antibiotic treatment

M3 - Report

BT - Scientific Opinion on the substantiation of a health claim related to fermented milk containing Lactobacillus casei DN-114 001 plus yoghurt symbiosis (Actimel®), and reduction of Clostridium difficile toxins in the gut of patients receiving antibiotics and reduced risk of acute diarrhoea in patients receiving antibiotics pursuant to Article 14 of Regulation (EC) No 1924/2006

PB - European Food Safety Authority

ER -

Tetens I. Scientific Opinion on the substantiation of a health claim related to fermented milk containing Lactobacillus casei DN-114 001 plus yoghurt symbiosis (Actimel®), and reduction of Clostridium difficile toxins in the gut of patients receiving antibiotics and reduced risk of acute diarrhoea in patients receiving antibiotics pursuant to Article 14 of Regulation (EC) No 1924/2006: EFSA-Q-2009-00776. European Food Safety Authority, 2010.